Other research found that 50-100 mcg per day was effective, with higher doses showing diminishing returns on GH but increasing returns on side effects
In the prescription medication industry, there are single glucagon-like peptide-1 (GLP-1) receptor agonist options (weight loss injections) and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist options that are marketed for the treatment of diabetes, obesity, and weight management solutions
Interestingly, GLP-1R knockout mice were reported to exhibit similar or increased insulin secretion compared to wild-type mice in response to glucose loads, with glucose tolerance maintained in a recent study
Yang J, Balog B, Deng K, Hanzlicek B, Rietsch A, Kuang M, et al
It is known that glucose can form adducts with glutathione, which can in part explain the observed differences 36
Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM